Role of innate immunity in the pathogenesis of allergic rhinitis

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 20, Issue 3, 2012, Pages 194-198

  Melvin, Thuy Anh N ^a   Ramanathan, Murugappan ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

allergic rhinitis; chitinase; innate immunity; mucus; pathogenesis; surfactant protein; therapy; toll like

Indexed keywords

CHITINASE; CORTICOSTEROID; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR AGONIST;

ADAPTIVE IMMUNITY; ALLERGIC RHINITIS; CYTOKINE PRODUCTION; DRUG EFFECT; ENVIRONMENTAL FACTOR; HUMAN; INNATE IMMUNITY; NATURAL KILLER T CELL; NOSE MUCOSA; PATHOGENESIS; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; RESPIRATORY TRACT ALLERGY; REVIEW; TH2 CELL;

EID: 84862089589     PISSN: 10689508     EISSN: 15316998     Source Type: Journal    
DOI: 10.1097/MOO.0b013e3283533632     Document Type: Review

References (38)

1. Reed SD, Lee TA, McCrory DC. The economic burden of allergic rhinitis: a critical evaluation of the literature. Pharmacoeconomics 2004; 22:345-361.
2. Anand VK. Epidemiology and economic impact of rhinosinusitis. Ann Otol Rhinol Laryngol Suppl 2004; 193:3-5.
3. Blaiss M. Current concepts and therapeutic strategies for allergic rhinitis in school-age children. Clin Ther 2004; 26:1876-1889.
4. Santos CB, Pratt EL, Hanks C, et al. Allergic rhinitis and its effect on sleep, fatigue, and daytime somnolence. Ann Allergy Asthma Immunol 2006; 97:579-586; quiz 586-589, 671.
5. Schenten D, Medzhitov R. The control of adaptive immune responses by the innate immune system. Adv Immunol 2011; 109:87-124.
6. Iwasaki A, Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science 2010; 327:291-295.
7. Ramanathan M Jr, Lee WK, Dubin MG, et al. Sinonasal epithelial cell expression of toll-like receptor 9 is decreased in chronic rhinosinusitis with polyps. Am J Rhinol 2007; 21:110-116.
8. Wang Y, Bai C, Li K, et al. Role of airway epithelial cells in development of asthma and allergic rhinitis. Respir Med 2008; 102:949-955.
9. Kirtsreesakul V, Somjareonwattana P, Ruttanaphol S. The correlation between nasal symptom and mucociliary clearance in allergic rhinitis. Laryngoscope 2009; 119:1458-1462.
10. Vlastos I, Athanasopoulos I, Mastronikolis NS, et al. Impaired mucociliary clearance in allergic rhinitis patients is related to a predisposition to rhinosinusitis. Ear Nose Throat J 2009; 88:E17-E19.
11. Kaur S, Gupta VK, Shah A, et al. Elevated levels of mannan-binding lectin [corrected] (MBL) and eosinophilia in patients of bronchial asthma with allergic rhinitis and allergic bronchopulmonary aspergillosis associate with a novel intronic polymorphism in MBL. Clin Exp Immunol 2006; 143:414-419.
12. Deng Y, Chen S, Chen J, et al. Relationship between surfactant protein A polymorphisms and allergic rhinitis in a Chinese Han population. Mol Biol Rep 2011; 38:1475-1482.
13. Madan T. Potential of lung surfactant proteins, SP-A and SP-D, and mannan binding lectin for therapy and genetic predisposition to allergic and invasive aspergillosis. Recent Pat Inflamm Allergy Drug Discov 2007; 1:183-187.
14. Rampey AM, Lathers DM, Woodworth BA, Schlosser RJ. Immunolocalization of dendritic cells and pattern recognition receptors in chronic rhinosinusitis. Am J Rhinol 2007; 21:117-121.
15. Vandermeer J, Sha Q, Lane AP, Schleimer RP. Innate immunity of the sinonasal cavity: expression of messenger RNA for complement cascade components and toll-like receptors. Arch Otolaryngol Head Neck Surg 2004; 130:1374-1380.
16. Fransson M, Benson M, Erjefalt JS, et al. Expression of Toll-like receptor 9 in nose, peripheral blood and bone marrow during symptomatic allergic rhinitis. Respir Res 2007; 8:17.
17. Melvin TA, Lane AP, Nguyen MT, Lin SY. Allergic rhinitis patients with recurrent acute sinusitis have increased sinonasal epithelial cell TLR9 expression. Otolaryngol Head Neck Surg 2010; 142:659-664.
18. Melvin TA, Nguyen MT, Lane AP, Lin SY. Allergic rhinitis is associated with decreased expression of Toll-like receptor 9 by sinonasal epithelial cells. Int Forum Allergy Rhinol 2011; 1:153-156.
19. Zhang G, Candelaria P, Makela JM, et al. Disparity of innate immunity-related gene effects on asthma and allergy on Karelia. Pediatr Allergy Immunol 2011; 22:621-630.
20. von Mutius E, Radon K. Living on a farm: impact on asthma induction and clinical course. Immunol Allergy Clin North Am 2008; 28:631-647; ix-x.
21. Eder W, Klimecki W, Yu L, et al. Toll-like receptor 2 as a major gene for asthma in children of European farmers. J Allergy Clin Immunol 2004; 113:482-488.
22. Kang I, Oh YK, Lee SH, et al. Identification of polymorphisms in the Toll-like receptor gene and the association with allergic rhinitis. Eur Arch Otorhinolaryngol 2010; 267:385-389.
23. Akbar NA, Zacharek MA. Vitamin D: immunomodulation of asthma, allergic rhinitis, and chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 2011; 19:224-228.
24. Baena-Cagnani CE, Gomez RM, Baena-Cagnani R, Canonica GW. Impact of environmental tobacco smoke and active tobacco smoking on the development and outcomes of asthma and rhinitis. Curr Opin Allergy Clin Immunol 2009; 9:136-140.
25. Senthilselvan A, Rennie D, Chenard L, et al. Association of polymorphisms of toll-like receptor 4 with a reduced prevalence of hay fever and atopy. Ann Allergy Asthma Immunol 2008; 100:463-468.
26. Lalaker A, Nkrumah L, Lee WK, et al. Chitin stimulates expression of acidic mammalian chitinase and eotaxin-3 by human sinonasal epithelial cells in vitro. Am J Rhinol Allergy 2009; 23:8-14.
27. Cho WS, Kim TH, Lee HM, et al. Increased expression of acidic mammalian chitinase and chitotriosidase in the nasal mucosa of patients with allergic rhinitis. Laryngoscope 2010; 120:870-875.
28. Jahnsen FL, Lund-Johansen F, Dunne JF, et al. Experimentally induced recruitment of plasmacytoid (CD123high) dendritic cells in human nasal allergy. J Immunol 2000; 165:4062-4068.
29. Okamoto Y, Horiguchi S, Yamamoto H, et al. Present situation of cedar pollinosis in Japan and its immune responses. Allergol Int 2009; 58:155-162.
30. Mesdaghi M, Vodjgani M, Salehi E, et al. Natural killer cells in allergic rhinitis patients and nonatopic controls. Int Arch Allergy Immunol 2010; 153:234-238.
31. Blaiss MS. Safety considerations of intranasal corticosteroids for the treatment of allergic rhinitis. Allergy Asthma Proc 2007; 28:145-152.
32. Schleimer RP. Glucocorticoids suppress inflammation but spare innate immune responses in airway epithelium. Proc Am Thorac Soc 2004; 1:222-230.
33. Ohnishi H, Miyahara N, Gelfand EW. The role of leukotriene B(4) in allergic diseases. Allergol Int 2008; 57:291-298.
34. Nguyen TH, Casale TB. Immune modulation for treatment of allergic disease. Immunol Rev 2011; 242:258-271.
35. Hayashi T, Raz E. TLR9-based immunotherapy for allergic disease. Am J Med 2006; 119:897 e1-e6.
36. Li DQ, Zhang L, Pflugfelder SC, et al. Short ragweed pollen triggers allergic inflammation through Toll-like receptor 4-dependent thymic stromal lymphopoietin/ OX40 ligand/OX40 signaling pathways. J Allergy Clin Immunol 2011; 128:1318-1325.e2.
37. Casale TB, Kessler J, Romero FA. Safety of the intranasal toll-like receptor 4 agonist CRX-675 in allergic rhinitis. Ann Allergy Asthma Immunol 2006; 97:454-456.
38. Allam JP, Bieber T, Novak N. Dendritic cells as potential targets for mucosal immunotherapy. Curr Opin Allergy Clin Immunol 2009; 9:554-557.